Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eisai Ltd ADR
(OP:
ESALY
)
N/A
UNCHANGED
Last Price
Updated: 3:59 PM EST, Jan 30, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eisai Ltd ADR
< Previous
1
2
3
4
5
6
7
Next >
Joblessness Surprise
July 22, 2021
Despite higher production for the Emirates the price of oil rose sharply today. More output should cut prices.
Via
Talk Markets
The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO
July 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) Biohaven Pharmaceutical...
Via
Benzinga
Exposures
Product Safety
“Claw-Back” day
July 20, 2021
The rally was just as irrational as the selloff.
Via
Talk Markets
Delta Defeats Bulls
July 19, 2021
Stocks tended to crash without rhyme or reason.
Via
Talk Markets
Weak Week
July 16, 2021
Friday tried a recovery because retail sales data for June were strong, particularly in dining out, although in the end, the weak tech side cut the optimism.
Via
Talk Markets
Biogen's Alzheimer's Drug Aduhelm Review Could Have Been Handled Differently, Says FDA Chief: STAT News
July 15, 2021
Acting FDA Commissioner Janet Woodcock pushed back against media questions about the agency's controversial approval of Alzheimer's treatment, Aduhelm developed by ...
Via
Benzinga
Exposures
Product Safety
Dialing For Stocks
July 14, 2021
Thanks to Fed Chairman Powell, markets brushed off worrying about inflation today.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
FDA Narrows Label To Recommend Use Of Biogen's Aduhelm In Mild Alzheimer's Patients
July 08, 2021
Biogen Inc. (NASDAQ:BIIB) shares are lower after the compa...
Via
Benzinga
Exposures
Product Safety
People Needed
July 02, 2021
If qualified people are not looking for work, they will have to be lured to do so with higher wages.
Via
Talk Markets
Exposures
Labor
End Of June
June 30, 2021
Canadian Solar fell 4.6% on fears of plans for a China IPO where its panels are made.
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Summer Friday
June 25, 2021
The stock market tried for another record after yesterday's late blowout over the infrastructure deal.
Via
Talk Markets
Crazy Thursday
June 24, 2021
Today the US stock market went ballistic probably because of a higher joblessness level than expected.
Via
Talk Markets
Wednesday Is A Normal Day
June 23, 2021
Meme stocks Gamestop and Torchlight Energy both did share sales to cash in on their share price rises.
Via
Talk Markets
The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO
June 24, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ...
Via
Benzinga
The First Day Of Summer And Prime Day
June 21, 2021
The bull is back in business today.
Via
Talk Markets
3 More Reasons Biogen's Alzheimer's Drug Will Underperform Wall Street Expectations
June 20, 2021
Beyond its lofty price tag, there are other impediments to big sales of aducanamab that the market largely ignored this week.
Via
The Motley Fool
Did This Company Just Win Big Because of Biogen?
June 20, 2021
Alzheimer's disease patients who take Aduhelm will need a lot of diagnostic scans, too. Imaging leader RadNet stands to benefit.
Via
The Motley Fool
Exposures
Product Safety
The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs
June 18, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ...
Via
Benzinga
Exposures
Product Safety
Bristol Myers Inks Licensing Pact For Eisai's Folate Receptor ADC Drug, Lays Out Over $3B For Rights
June 18, 2021
Eisai Co Ltd (OTC: ESALY) and Bristol-Myers Squibb Co (NYSE: BMY) have entered into an exclusive global strategic collaboration agreement for the co-...
Via
Benzinga
Two Rate Hikes In 2023
June 16, 2021
This afternoon our Fed chief Jerome Powell predicted there will be interest rate hikes faster than before. The news hit US stocks, gold, and bitcoin hard.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Continued Uncertainty
June 15, 2021
Fear of another Fukushima yesterday late in the market day led to a rush out of energy-related shares, which included many without any nuclear risk at all.
Via
Talk Markets
Dreary Day
June 14, 2021
Another dreary day and a renewed boost for cryptocurrency - and away from the classic inflation hedge, gold.
Via
Talk Markets
Happy Friday
June 11, 2021
The inflation risk is being ignored by the US market now that there will probably not be a tax increase and may be higher prices for longer.
Via
Talk Markets
Unheeding Markets
June 10, 2021
Today oil prices rose over $70.
Via
Talk Markets
Wednesday News And Catch-Up
June 09, 2021
Today the US market resumed its attempt to hit a new record for the S&P 500 and Nasdaq, but not the DJIA.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
FDA surprise
June 07, 2021
The big news out of China is that its import purchases of copper and iron sagged last month because its export markets are far less strong than earlier this year.
Via
Talk Markets
Exposures
Product Safety
Biogen's Alzheimer's Disease Treatment Earns FDA Approval
June 07, 2021
Aducanumab becomes the first available treatment intended to stop patients with Alzheimer's disease from losing more memories.
Via
The Motley Fool
Exposures
Product Safety
Why Biogen Stock Is On Fire Today
June 07, 2021
The biotech's controversial Alzheimer's disease drug got a green light from the FDA.
Via
The Motley Fool
Exposures
Product Safety
Merck/Eisai's Keytruda-Lenvima Combo Results in Better Health-Related Quality of Life Measures Compared to Sunitinib
June 07, 2021
Merck & Co Inc (NYSE: MRK) has announced new data from Phase 3 CLEAR (Study 307)/KEYNOTE-581 trial, which evaluated the combinations of Keytruda (pembrolizumab...
Via
Benzinga
A Better Switch
June 04, 2021
Today the US market decided to rise because President Biden is pondering not linking his infrastructure project to a corporate tax increase.
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.